Development of an Anti-Egfr/Anti-Cd3/Anti-Mpeg Trispecific Antibody to Synergistically Enhance the Anti-Cancer Efficacy of Immuno-Enhancing Drug-Loaded Mpeg-Nanocarriers and T Cells in Tumor Microenvironment of Colorectal Cancer( I )

Project: A - Government Institution › b - National Science and Technology Council

Project Details

StatusFinished
Effective start/end date8/1/20 → 7/1/21